What is the Ownership and Shareholding Structure of Karak Pharmaceuticals?
In 2017, Karak Pharmaceuticals had a promoter holding of 42.35% and a public holding of 57.65%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.










Company Details
+91-XXXXXXXXXX